HNN3.0
Register
Register
Register

Project cooperationUpdated on 2 December 2025

Medicinal Chemistry Partnerships for Targeted Therapeutic Innovation

Associate Professor at University "G. d'Annunzio" of Chieti-Pescara

Chieti, Italy

About

The UdA MedChemLab offers a dynamic, collaborative environment for the co-development and implementation of cutting-edge research initiatives and preclinical studies focused on long-term care, prevention, and management of non-communicable diseases, including cancer, inflammatory disorders, and immune-related conditions.

Our research interests center on the application of tailored, targeted therapeutic strategies in relevant disease models to improve screening approaches and enhance the prediction of therapeutic efficacy and safety.

We are seeking partners with complementary expertise to join multidisciplinary consortia and collaboratively develop impactful, innovation-driven projects.

Topic

  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)
  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health

Organisation

Similar opportunities

  • Project cooperation

    Experts for electrophysiology tackle functional aspects in cardiovascular diseases

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways

    Katarina Danko

    researcher at Department of Biophysics and Electrophysiology, Centre of Biosciences, Slovak Academy of Sciences

    Bratislava, Slovakia

  • Project cooperation

    Sex Differences in Cardiometabolism in Health and Disease

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways

    Lukas Chmatal

    Junior Group Leader at Institute of Physiology of the Czech Academy of Sciences

    Prague, Czech Republic

  • Project cooperation

    Multimodal Foundation AI Models for Cardiac and Healthcare Applications

    • Consortium/Coordinator seeks Partners
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways

    Alessandro Perelli

    Lecturer in Artificial Intelligence at University of Glasgow

    Glasgow, United Kingdom